Share-Value Dilution from the Exercise of Stock Acquisition Rights
First written in FY2017. 7 of 19 entries say "Materialised", first in FY2019-Q2. Latest entry: FY2027-H1.
Media Do moved to the "Worse" side of this theme in 2022, 1 year after the typical company in this theme (2021).
The whole theme swung hardest in 2017: 28 of 54 companies on the "Worse" side.
56 other companies' latest entry also says "Materialised".
- FY2027-H1MaterialisedAnnual report
「6 July 2026」
38,253 shares were issued as specified restricted stock compensation, adding to dilution from stock-based compensation. The company disclosed that 218,595 shares had been issued as restricted stock compensation as of the end of the interim period. - 2026-06-18WorsenedShare Issuance and Disposal
「株式数：38,253 株」
譲渡制限付株式報酬として38,253株を新たに発行することにより、株式報酬による希薄化要因が追加されている。 - FY2026-H1WorsenedAnnual report
「Number of stock acquisition rights (rights)* 7,580 Class, details and number of shares underlying stock acquisition rights (shares)* Common shares 758,000」
The issuance of the 19th Series of Stock Acquisition Rights added 758,000 potential shares as a new source of dilution. - FY2025-Q1MaterialisedAnnual report
「The issuance of new shares as restricted stock compensation, with 5 July 2024 as the payment date, increased the total number of issued shares by 42,061 and increased share capital and the capital reserve by ¥30 million each.」
42,061 shares were issued as restricted stock compensation, adding to dilution from stock-based compensation. - FY2024-Q2MaterialisedAnnual report
「21 July 2023」
33,309 shares were issued as specified restricted stock compensation, adding to dilution from stock-based compensation. - FY2023-Q2Additional dilution from restricted stock compensationAnnual report
「12 July 2022 (Note) Increase resulting from the issuance of new shares as specified restricted stock compensation.」
30,686 shares were issued as specified restricted stock compensation, with part of the dilution from potential shares and compensation shares materializing as actual share issuance. - FY2022-Q1MitigatedAnnual report
「All of the 18th Series of Stock Acquisition Rights, which numbered 5,059 at the end of the previous consolidated fiscal year and represented 100 shares per right, were acquired and cancelled on 9 April 2021.」
All of the 18th Series of Stock Acquisition Rights were acquired and cancelled, eliminating the future source of dilution associated with those rights. - FY2021MaterialisedAnnual report
「The increase of 1,195,200 shares in the total number of issued common shares comprised 680,400 shares issued upon the exercise of the 18th Series of Stock Acquisition Rights, 508,900 shares issued upon the exercise of stock options and 5,900 shares issued as restricted stock.」
A total of 1,195,200 shares were issued through stock acquisition rights, stock options and restricted stock, adding to the realized dilution. - FY2021-Q3MaterialisedAnnual report
「Number of such convertible bonds with stock acquisition rights subject to adjustment of the exercise price exercised during the third quarter: 2,000 / Shares delivered upon exercise during the quarter: 200,000 / Between 1 December 2020 and 31 December 2020, the exercise of stock acquisition rights increased the total number of issued shares by 35,000 shares and increased both stated capital and capital surplus by ¥16 million.」
The exercise of the 18th Series of Stock Acquisition Rights resulted in the issuance of 200,000 shares during the quarter and a further 35,000 shares in December before the filing date, adding to the realized dilution. - FY2021-Q2WorsenedAnnual report
「Potential shares represented by this issuance: 1,186,300 shares (100 shares per stock acquisition right)」
The resolution to issue the 18th Series of Stock Acquisition Rights added 1,186,300 potential shares as a new source of dilution. - FY2021-Q1Additional dilutionAnnual report
「Between 1 June 2020 and 30 June 2020, the total number of issued shares increased by 81,000 shares through the exercise of stock acquisition rights, while share capital and the capital reserve each increased by ¥42 million.」
Following the exercise of stock acquisition rights after the end of the quarter, an additional 81,000 shares were issued, with part of the dilution from potential shares materializing as actual share issuance. - FY2020Additional dilutionAnnual report
「The increase of 1,834,000 shares in the total number of issued common shares resulted from the issuance of new shares upon the exercise of stock options.」
An additional 1,834,000 shares were issued through the exercise of stock acquisition rights, bringing the number of issued shares to 14,175,100. - FY2020-Q3Additional dilutionAnnual report
「1 September 2019–30 November 2019 (Note) 2,000 14,175,100 1,853 1,899,260 1,853 1,602,907」
An additional 2,000 shares were issued through the exercise of stock acquisition rights, with part of the dilution from potential shares materializing as actual share issuance. - FY2020-Q2Additional dilutionAnnual report
「1 June 2019–31 August 2019 (Note) 1 1,493,500 14,173,100 6,347 1,897,407 6,347 1,601,054」
An additional 1,493,500 shares were issued through the exercise of stock acquisition rights, with part of the dilution from potential shares materializing as actual share issuance. - FY2020-Q1Additional dilutionAnnual report
「Between 1 June 2019 and 30 June 2019, the exercise of stock acquisition rights increased the total number of issued shares by 1,493,500 shares and increased both stated capital and capital surplus by ¥6.347 million.」
Additional share issuance through the exercise of stock acquisition rights occurred, with part of the dilution from potential shares materializing as actual share issuance. - FY2019-Q3Additional dilutionAnnual report
「1 September 2018–30 November 2018 (Note) 1 720,500 12,169,800 511,926 1,469,330 511,926 1,172,977 / 31 October 2018 (Note) 2 7,800 12,177,600 9,730 1,479,060 9,730 1,182,707」
720,500 shares were issued through the exercise of stock acquisition rights and 7,800 shares through specified restricted stock compensation, with additional dilution from potential shares materializing as actual share issuance. - FY2019-Q2MaterialisedAnnual report
「29 June 2018: Increase in total number of issued shares: 40,000 shares / (Note) 1. Increase resulting from the exercise of stock acquisition rights. / 17 July 2018: Increase in total number of issued shares: 20,100 shares / (Note) 2. Increase resulting from the issuance of new shares as specified restricted stock compensation.」
40,000 shares were issued through the exercise of stock acquisition rights and 20,100 shares through restricted stock compensation, with part of the dilution from potential shares materializing as actual share issuance. - FY2018Expansion of dilution scope and numerical updateAnnual report
「In addition to the stock acquisition rights currently granted, the future grant of restricted stock may dilute the value of the shares held. As of 28 February 2018, the number of potential shares represented by stock acquisition rights was 3,403,500 shares and the number of restricted shares was 0 shares, representing 23.0% of the total number of issued shares plus potential shares represented by stock acquisition rights and other instruments.」
The number of potential shares was updated to 3,403,500 and the ratio to 23.0%, and the company also indicated the potential for dilution from restricted shares in addition to the existing stock acquisition rights. - FY2017First statedAnnual report
「As of 28 February 2017, the number of potential shares from stock acquisition rights was 3,046,200, equivalent to 23.3% of the total number of issued shares plus potential shares from stock acquisition rights and other instruments.」
Discloses potential dilution of 3,046,200 shares, equivalent to 23.3% of issued shares plus other potential shares.